Claims-Based Frailty Index as a Measure of Dementia Severity in Medicare Claims Data

Author:

Park Chan Mi12ORCID,Sison Stephanie Denise M3,McCarthy Ellen P12,Shi Sandra12ORCID,Gouskova Natalia1,Lin Kueiyu Joshua4,Kim Dae Hyun12ORCID

Affiliation:

1. Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife , Boston, Massachusetts , USA

2. Division of Gerontology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, Massachusetts , USA

3. Division of General Internal Medicine, University of Massachusetts Chan Medical School , Worcester, Massachusetts , USA

4. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School , Boston, Massachusetts , USA

Abstract

Abstract Background Dementia severity is unavailable in administrative claims data. We examined whether a claims-based frailty index (CFI) can measure dementia severity in Medicare claims. Methods This cross-sectional study included the National Health and Aging Trends Study Round 5 participants with possible or probable dementia whose Medicare claims were available. We estimated the Functional Assessment Staging Test (FAST) scale (range: 3 [mild cognitive impairment] to 7 [severe dementia]) using information from the survey. We calculated CFI (range: 0–1, higher scores indicating greater frailty) using Medicare claims 12 months prior to the participants’ interview date. We examined C-statistics to evaluate the ability of the CFI in identifying moderate-to-severe dementia (FAST stage 5–7) and determined the optimal CFI cut-point that maximized both sensitivity and specificity. Results Of the 814 participants with possible or probable dementia and measurable CFI, 686 (72.2%) patients were ≥75 years old, 448 (50.8%) were female, and 244 (25.9%) had FAST stage 5–7. The C-statistic of CFI to identify FAST stage 5–7 was 0.78 (95% confidence interval: 0.72–0.83), with a CFI cut-point of 0.280, achieving the maximum sensitivity of 76.9% and specificity of 62.8%. Participants with CFI ≥0.280 had a higher prevalence of disability (19.4% vs 58.3%) and dementia medication use (6.0% vs 22.8%) and higher risk of mortality (10.7% vs 26.3%) and nursing home admission (4.5% vs 10.6%) over 2 years than those with CFI <0.280. Conclusions Our study suggests that CFI can be useful in identifying moderate-to-severe dementia from administrative claims among older adults with dementia.

Funder

National Institute on Aging

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Geriatrics and Gerontology,Aging

Reference33 articles.

1. 2019 Alzheimer’s disease facts and figures;Alzheimer’s Association,2019

2. Identifying Medicare beneficiaries with dementia;Moura;J Am Geriatr Soc.,2021

3. Validation of claims algorithms to identify Alzheimer’s disease and related dementias;McCarthy;J Gerontol A Biol Sci Med Sci.,2022

4. Functional assessment staging (FAST) in Alzheimer’s disease: reliability, validity, and ordinality;Sclan;Int Psychogeriatr.,1992

5. The Global Deterioration Scale for assessment of primary degenerative dementia;Reisberg;Am J Psychiatry.,1982

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3